Teleflex Inc income statement
In fiscal 2025, Teleflex Inc reported revenue of $1.99bn, up 17.2% on the year before, operating income of $118m (a 5.9% margin) and net income of −$906m, or −$20.25 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,435 | 1,398 | 1,493 | 1,551 | 1,696 | 1,840 | 1,810 | 1,868 | 2,146 | 2,448 | 2,595 | 2,537 | 2,810 | 2,791 | 1,712 | 1,700 | 1,993 | 2,255 |
| Cost of revenue | — | — | — | — | — | — | — | 872 | 975 | 1,146 | 1,186 | 1,212 | 1,260 | 1,260 | 672 | 662 | 872 | 690 |
| Gross profit | 686 | 679 | 709 | 748 | 839 | 942 | 944 | 996 | 1,172 | 1,303 | 1,409 | 1,325 | 1,550 | 1,531 | 1,040 | 1,037 | 1,121 | 1,239 |
| Research and development | 37 | 42 | 49 | 56 | 65 | 61 | 52 | 59 | 85 | 106 | 114 | 120 | 131 | 154 | 114 | 109 | 145 | 159 |
| Selling, general and administrative | 388 | 404 | 424 | 454 | 502 | 579 | 569 | 563 | 700 | 797 | 852 | 744 | 860 | 864 | 623 | 675 | 720 | 722 |
| Operating income | 250 | 230 | 230 | −97 | 233 | 285 | 316 | 319 | 372 | 322 | 427 | 423 | 628 | 500 | 259 | 104 | 118 | 44 |
| Interest expense | 89 | 80 | 70 | 70 | 57 | 65 | 61 | 55 | 83 | 103 | 80 | 66 | 57 | 54 | 85 | 84 | 100 | 114 |
| Income before tax | 164 | 105 | 145 | −165 | 176 | 220 | 245 | 246 | 285 | 220 | 340 | 358 | 559 | 446 | 185 | 26 | 25 | −178 |
| Income tax | 37 | 17 | 26 | 16 | 24 | 29 | 8 | 8 | 130 | 23 | −122 | 22 | 74 | 83 | 42 | −31 | −34 | −56 |
| Net income | 303 | 201 | 323 | −190 | 151 | 188 | 245 | 237 | 153 | 201 | 461 | 335 | 485 | 363 | 356 | 70 | −906 | −1,032 |
| Diluted EPS | $7.59 | $4.99 | $7.92 | −$4.65 | $3.45 | $4.04 | $5.10 | $4.98 | $3.27 | $4.29 | $9.80 | $7.09 | $10.23 | $7.68 | $7.53 | $1.48 | −$20.25 | −$23.37 |
| Diluted shares (average) | 40m | 40m | 41m | 41m | 44m | 46m | 48m | 48m | 47m | 47m | 47m | 47m | 47m | 47m | 47m | 47m | 45m | 44m |
| EBITDA | 297 | 320 | 326 | −2 | 341 | 412 | 441 | 448 | 533 | 536 | 646 | 650 | 865 | 730 | 407 | 265 | 296 | 193 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 426 | 442 | 414 | 443 | 567 | 569 | 548 | 570 |
| Cost of revenue | 334 | −327 | 159 | 177 | 461 | −250 | 241 | 239 |
| Gross profit | 260 | 269 | 255 | 266 | 292 | 307 | 307 | 332 |
| Research and development | 39 | −8 | 25 | 26 | 57 | 13 | 44 | 45 |
| Selling, general and administrative | 247 | −66 | 153 | 138 | 282 | 1 | 226 | 214 |
| Operating income | 72 | 52 | 76 | 91 | −62 | 14 | 20 | 73 |
| Interest expense | 21 | 19 | 19 | 22 | 32 | 28 | 26 | 28 |
| Income before tax | 131 | −176 | 59 | 71 | −439 | 219 | −4 | 45 |
| Income tax | 20 | −26 | 6 | 2 | −30 | −31 | 1 | 3 |
| Net income | 111 | −137 | 95 | 123 | −409 | −714 | −8 | 100 |
| Diluted EPS | $2.36 | −$2.93 | $2.07 | $2.77 | −$9.24 | −$16.15 | −$0.18 | $2.28 |
| EBITDA | 141 | 11 | 114 | 128 | 15 | −19 | 74 | 123 |
Compare with peers
- Enovis Corp income statement
- Quidelortho Corp income statement
- Integer Holdings Corp income statement
- Revvity income statement
- Insulet Corporation income statement
Head to head: ENOV vs TFXQDEL vs TFXITGR vs TFX
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies